Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hoff

Showing results (431-440 of 514) with videos related to

Pageof 52
Sort By:
Oncogenesis|May 17, 2019
Transcriptional and functional consequences of TP53 splice mutations in colorectal cancerJørgen Smeby, Anita Sveen, Ina A Eilertsen, et al.
Diseases of the Colon and Rectum|March 9, 2016
Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal CancerSergio Carlos Nahas, Caio Sergio Rizkallah Nahas, Carlos Frederico Sparapan Marques, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2004
Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LVK Shirao, P M Hoff, A Ohtsu, et al.
The American Journal of Gastroenterology|February 9, 2022
Endoscopic Vacuum Therapy for Duodenal Hemorrhage in Critically Ill Patients With COVID-19Diogo T H de Moura, Eduardo G H de Moura, Bruno S Hirsch, et al.
Journal of the National Cancer Institute|January 19, 2018
The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and ThrombocytopeniaMichael J Overman, Renata Ferrarotto, Kanwal Raghav, et al.
Breast Care (Basel, Switzerland)|November 19, 2014
Cardiac safety of (neo)adjuvant trastuzumab in the community setting: a single-center experienceLeonardo Gomes da Fonseca, Debora de Melo Gagliato, Tiago K Takahashi, et al.
Infection Control and Hospital Epidemiology|February 9, 2018
Research Agenda for Antimicrobial Stewardship in the Veterans Health AdministrationKatie J Suda, Daniel J Livorsi, Michihiko Goto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2007
Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 studyLeonard B Saltz, Heinz-Josef Lenz, Hedy L Kindler, et al.
International Journal of Evidence-Based Healthcare|February 4, 2017
Integrated care pathway for rectal cancer treatment: health care resource utilization, costs, and outcomesSilvia T Kobayashi, Maria D P E Diz, Alessandro G Campolina, et al.
Clinical Colorectal Cancer|June 6, 2016
Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal CancerVanessa C Miranda, Maria Ignez Braghiroli, Luiza Dib Faria, et al.
Pageof 52

Showing results (431-440 of 514) with videos related to

Sort By:
Pageof 52
Oncogenesis|May 17, 2019
Transcriptional and functional consequences of TP53 splice mutations in colorectal cancerJørgen Smeby, Anita Sveen, Ina A Eilertsen, et al.
Diseases of the Colon and Rectum|March 9, 2016
Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal CancerSergio Carlos Nahas, Caio Sergio Rizkallah Nahas, Carlos Frederico Sparapan Marques, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 28, 2004
Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: joint United States and Japan study of UFT/LVK Shirao, P M Hoff, A Ohtsu, et al.
The American Journal of Gastroenterology|February 9, 2022
Endoscopic Vacuum Therapy for Duodenal Hemorrhage in Critically Ill Patients With COVID-19Diogo T H de Moura, Eduardo G H de Moura, Bruno S Hirsch, et al.
Journal of the National Cancer Institute|January 19, 2018
The Addition of Bevacizumab to Oxaliplatin-Based Chemotherapy: Impact Upon Hepatic Sinusoidal Injury and ThrombocytopeniaMichael J Overman, Renata Ferrarotto, Kanwal Raghav, et al.
Breast Care (Basel, Switzerland)|November 19, 2014
Cardiac safety of (neo)adjuvant trastuzumab in the community setting: a single-center experienceLeonardo Gomes da Fonseca, Debora de Melo Gagliato, Tiago K Takahashi, et al.
Infection Control and Hospital Epidemiology|February 9, 2018
Research Agenda for Antimicrobial Stewardship in the Veterans Health AdministrationKatie J Suda, Daniel J Livorsi, Michihiko Goto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 19, 2007
Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 studyLeonard B Saltz, Heinz-Josef Lenz, Hedy L Kindler, et al.
International Journal of Evidence-Based Healthcare|February 4, 2017
Integrated care pathway for rectal cancer treatment: health care resource utilization, costs, and outcomesSilvia T Kobayashi, Maria D P E Diz, Alessandro G Campolina, et al.
Clinical Colorectal Cancer|June 6, 2016
Phase 2 Trial of Metformin Combined With 5-Fluorouracil in Patients With Refractory Metastatic Colorectal CancerVanessa C Miranda, Maria Ignez Braghiroli, Luiza Dib Faria, et al.
Pageof 52